Boston Scientific Pacemaker Recall for Software Update
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Boston Scientific Corporation is recalling various pacemaker models due to an available software update, affecting 718,456 units worldwide.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 13, 2026 and geographically references worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Devices.
What Happened
Boston Scientific Corporation is issuing a recall for updated software, known as Brady software maintenance release 6 (SMR6), for certain pacemakers. This recall expands the advisory population to include all cardiac resynchronization therapy pacemakers (CRT-Ps) and dual-chamber extended life (DR-EL) devices, as they are used for treating conduction disorders, AV block, VVI intolerance, and related heart conditions.
Which Products Are Affected
The affected products are Boston Scientific Pacemakers, with the following model numbers: ESSENTIO SR SL (L100), ESSENTIO DR SL (L101), ESSENTIO SR SL MRI (L110), ESSENTIO DR SL MRI (L111), ESSENTIO DR EL (L121), ESSENTIO DR EL MRI (L131), PROPONENT SR SL (L200), PROPONENT DR SL (L201), PROPONENT DR (VDD) SL (L209), PROPONENT SR SL (L210), PROPONENT DR SL MRI (L211), PROPONENT DR EL (L221), PROPONENT DR EL MRI (L231), ACCOLADE SR SL (L300), ACCOLADE DR SL (L301), ACCOLADE SR SL MRI (L310), ACCOLADE DR SL MRI (L311), ACCOLADE DR EL (L321), ACCOLADE DR EL MRI (L331), ALTRUA 2 SR SL (S701), ALTRUA 2 DR SL (S702), and ALTRUA 2 DR EL (S722). A total of 718,456 units are affected. The advisory includes all serialized DR-EL pacemakers and CRT-Ps from the ACCOLADE family, and ACCOLADE DR-SL and SR-SLs with a use-by-date on or before June 30, 2025. Distribution is worldwide, and to check if a device is affected, use the device lookup tool at www.BostonScientific.com/lookup with the model and serial number. The recall number is Z-1770-2026.
What You Should Do
Consumers should check if their device is affected by entering the model and serial number into the device lookup tool at www.BostonScientific.com/lookup. Contact Boston Scientific Corporation for further instructions, as the source data indicates the recall was initiated via letter.
Why This Matters
This recall affects a significant number of pacemaker devices used for critical heart conditions, potentially ensuring better device performance and patient safety through software updates.
Source
FDA recall notice, recall number Z-1770-2026, available through the FDA website.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (2,121 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to May 13, 2026.
Frequently Asked Questions
Common questions about this FDA recall.